ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,893.32
      -0.23%
      US Tech 100
      20,507.20
      -0.57%
      Dow Jones
      42,543.17
      -0.07%
      Brent Oil
      74.805
      0.95%
      Bitcoin
      94,083.43
      1.53%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Lantheus Holdings Inc (LNTH) Quote

      Lantheus Holdings Inc

      Lantheus Holdings Inc (LNTH)

      NASDAQ
      90.01
      0.88
      ( 0.99% )
      Updated: 12:56:58
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      90.01
      Bid
      89.94
      Ask
      90.21
      Volume
      151,487
      89.13 Day's Range 90.37
      50.20 52 Week Range 126.8899
      Market Cap
      6.258B
      Previous Close
      89.13
      Open
      89.72
      Last Trade
      1
      @
      90.075
      Last Trade Time
      12:57:28
      Financial Volume
      $ 13,586,771
      VWAP
      89.6894
      Average Volume (3m)
      1,037,581
      Shares Outstanding
      69,526,841
      Dividend Yield
      -
      PE Ratio
      19.09
      Earnings Per Share (EPS)
      4.7
      Revenue
      1.3B
      Net Profit
      326.66M

      About Lantheus Holdings Inc

      Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in ... Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. Its portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States. Show more

      Sector
      In Vitro,in Vivo Diagnostics
      Industry
      In Vitro,in Vivo Diagnostics
      Website
      www.lantheus.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Lantheus Holdings Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker LNTH. The last closing price for Lantheus was $89.13. Over the last year, Lantheus shares have traded in a share price range of $ 50.20 to $ 126.8899.

      Lantheus currently has 69,526,841 shares outstanding. The market capitalization of Lantheus is $6.20 billion. Lantheus has a price to earnings ratio (PE ratio) of 19.09.

      Ask ADVFN Intelligence (AI)

      Lantheus (LNTH) Options Flow Summary

      LNTH Options Flow

      Overall Flow

      Bearish

      Net Premium

      -26k

      Calls / Puts

      0.00%

      Buys / Sells

      0.00%

      OTM / ITM

      100.00%

      Sweeps Ratio

      0.00%

      LNTH Latest News

      More News

      Form 8-K - Current report

      December 23 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      December 19 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 20 2024
      Edgar (US Regulatory)

      Lantheus Announces Share Repurchase Program

      BEDFORD, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling...

      November 20 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      November 19 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      November 18 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      November 15 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      November 14 2024
      Edgar (US Regulatory)

      Lantheus to Present at the Jefferies London Healthcare Conference

      BEDFORD, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find...

      November 13 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      November 12 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-1.56-1.7036147209891.5793.2989.0937511191.41038944CS
      40.780.87414546677189.2396.06586.7281857190.97492372CS
      12-17.27-16.0980611484107.28118.2175103758193.35439265CS
      269.6612.022401991380.35126.8899751017938100.85897856CS
      5228.1145.411954765861.9126.889950.2100136283.39916612CS
      15660.48204.8086691529.53126.889923.51108248472.16109967CS
      26069.83346.0356788920.18126.88998.6785762358.80904326CS

      LNTH - Frequently Asked Questions (FAQ)

      What is the current Lantheus share price?
      The current share price of Lantheus is $ 90.01
      How many Lantheus shares are in issue?
      Lantheus has 69,526,841 shares in issue
      What is the market cap of Lantheus?
      The market capitalisation of Lantheus is USD 6.2B
      What is the 1 year trading range for Lantheus share price?
      Lantheus has traded in the range of $ 50.20 to $ 126.8899 during the past year
      What is the PE ratio of Lantheus?
      The price to earnings ratio of Lantheus is 19.09
      What is the cash to sales ratio of Lantheus?
      The cash to sales ratio of Lantheus is 4.81
      What is the reporting currency for Lantheus?
      Lantheus reports financial results in USD
      What is the latest annual turnover for Lantheus?
      The latest annual turnover of Lantheus is USD 1.3B
      What is the latest annual profit for Lantheus?
      The latest annual profit of Lantheus is USD 326.66M
      What is the registered address of Lantheus?
      The registered address for Lantheus is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
      What is the Lantheus website address?
      The website address for Lantheus is www.lantheus.com
      Which industry sector does Lantheus operate in?
      Lantheus operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BDMDBaird Medical Investment Holdings Ltd
      $ 6.3762
      (507.26%)
      		50.39M
      APMAptorum Group Ltd
      $ 4.52
      (233.58%)
      		104.75M
      ONCOOnconetix Inc
      $ 1.17
      (167.73%)
      		236.24M
      VRMEVerifyMe Inc
      $ 1.71
      (116.48%)
      		86.89M
      CGBSCrown LNG Holdings Ltd
      $ 0.5289
      (56.02%)
      		12.19M
      SGMOSangamo Therapeutics Inc
      $ 1.05
      (-55.13%)
      		27.01M
      WATTEnergous Corporation
      $ 1.295
      (-51.13%)
      		23.94M
      INTZIntrusion Inc
      $ 3.186
      (-43.91%)
      		12.2M
      NXUNXU Inc
      $ 0.9081
      (-39.46%)
      		67.58M
      IDAIT Stamp Inc
      $ 0.740001
      (-38.33%)
      		7.94M
      SVMHSRIVARU Holding Ltd
      $ 0.0446
      (33.53%)
      		725.14M
      EYENEyenovia Inc
      $ 0.15
      (32.39%)
      		361.7M
      XTIAXTI Aerospace Inc
      $ 0.03995
      (1.14%)
      		342.28M
      CRKNCrown Electrokinetics Corporation
      $ 0.1558
      (12.33%)
      		330.38M
      ONCOOnconetix Inc
      $ 1.17
      (167.73%)
      		236.24M

      LNTH Discussion

      View Posts
      bwolfy2002 bwolfy2002 6 months ago
      https://investor.lantheus.com/news-releases/news-release-details/lantheus-welcomes-cms-proposed-cy25-rule-improved-payment
      👍️0
      bwolfy2002 bwolfy2002 6 months ago
      “Shares of Lantheus Holdings (NASDAQ:LNTH) climbed on Wednesday after the Centers for Medicare and Medicaid Services (CMS) issued a draft proposal to improve payments for diagnostic radiopharmaceuticals…”

      From Seeking Alpha is all I could find.
      👍️0
      bwolfy2002 bwolfy2002 6 months ago
      What’s going on here?
      👍️0
      fung_derf fung_derf 12 months ago
      Don't know why you vanished, but you must be pissed you sold LNTH in August 2020 to buy CYDY.
      I know I would be!
      How were you talked into this?
      👍️0
      Chuckles759 Chuckles759 3 years ago
      Interesting 8K announcing Paul Blanchfield's move to COO.

      Anyone have background to share that's not in the "official press release" ?
      👍️0
      Chuckles759 Chuckles759 3 years ago
      I'm thinking that nothing of significance was announced/presented Thursday at the conference. More waiting.....
      👍️0
      Chuckles759 Chuckles759 3 years ago
      Any thoughts if something newsworthy will be announced on Thursday?

      Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find, Fight and Follow serious medical conditions, today announced Mary Anne Heino, President and Chief Executive Officer, and Bob Marshall, Chief Financial Officer and Treasurer, will present at the Jefferies Healthcare Conference at 11:00 a.m. ET on Thursday, June 9, in New York.
      To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for 30 days following the live presentation.
      👍️0
      make it happen make it happen 3 years ago
      $lnth covered in fake bots on this site. Very sketchy was $1.30. Had negative earnings.

      Only phase 2... long way to go & burning & hemeraging money with out phase 3 & more...

      Says "warning perception risk of image. Misinterpretation of imaging errors occur with Plyarify"
      👍️0
      Chuckles759 Chuckles759 3 years ago
      Can't fault Gerald Ber for cashing in a little on the upside price on Tuesday. Nice offset for the sale by the options just grante.

      I think the transaction came out to about $75K and he still holds 32K shares.

      I think the earnings announcement a couple of weeks ago posting around 100% over earlier estimates is really holding this up. They predict a $2.78 EPS for the current year. Not too shabby.
      👍️0
      Chuckles759 Chuckles759 3 years ago
      I'm wondering if the rumor of the royalties owed LNTH (via the ProGenics acquisition) by CytoDyn might be avoided somehow. But that was during Nader Pourhassan's tenure. New leadership at CytoDyn that sound a bit more "by the books".
      👍️0
      Chuckles759 Chuckles759 3 years ago
      Wow...nice bump today with the PR announcing the clinical trial using their proprietary technetium 99m SPECT imaging agent.

      This bears a much closer watching.
      👍️0
      Chuckles759 Chuckles759 3 years ago
      Crazy how it's held this price for so long. Should be an interesting ride.
      👍️0
      make it happen make it happen 3 years ago
      Phase 2 still has phase 3, fda approval, and so many other things and money burning to create a "potential" product. Will have to dilute the share structure to keep them alive. Pay employees, overhead, lease, the list goes on..... This shits getting ridiculous lmao
      👍️0
      make it happen make it happen 3 years ago
      I really feel like that are saying and putting out anything to keep it up here atm tick tock tick tick def a game of hot potato ??
      👍️0
      make it happen make it happen 3 years ago
      Double debt

      Profitability
      Profit Margin-6.89%

      MNGT Effectiveness
      Return on Equity -7.15%

      Balance Sheet - Double debt
      Total Cash 105.36M
      Total Cash Per Share $1.53
      Total Debt 190.07M
      👍️0
      make it happen make it happen 3 years ago
      Price $60 was $1.7

      Monthly RSI 75.8
      SMA 20 - $22.41
      SMA 50 - $29.09

      Weekly RSI weekly 69
      SMA 50 - $33.75
      SMA 200 - $21.91

      Gaps to fill. Maybe floating on thin air once prop is stopped IMO

      History shows dramatic drops when RSI's overbought for a extended time
      👍️0
      make it happen make it happen 3 years ago
      The insiders barley have any left. It's institutions only right now and little retail. It was a lock and run we should see $35 again quick and that's still well over 10x revs. Never seen a prop for so many months.
      👍️0
      make it happen make it happen 3 years ago
      RSI is way over bought on daily, weekly and monthly.

      Weekly SMA's 200 day $20.49 & 50 day $29.05

      A correction to a the SMA should happen imo

      How can it add billions and have a wider loss than has ever had of 72 million?
      👍️0
      make it happen make it happen 3 years ago
      All negatives... Negative profitability, management effectiveness and Net income to common.

      Profitability
      Profit Margin -16.76%
      Operating Margin (ttm) 0.90%

      Management Effectiveness
      Return on Assets (ttm) 0.27%
      Return on Equity (ttm) -14.57%

      Income Statement
      Revenue (ttm) 425.21M
      Revenue Per Share (ttm) 6.30
      Net Income Avi to Common (ttm) -71.28M
      Diluted EPS (ttm) -1.06

      Balance Sheet
      Total Cash (mrq) 98.51M
      Total Cash Per Share (mrq) 1.45
      Total Debt (mrq) 193.26M
      👍️0
      make it happen make it happen 3 years ago
      I guess were going to the moon on over a 70 million dollar loss makes financial sense
      👍️0
      make it happen make it happen 3 years ago
      Up over 75% in days ='s about $2,300,000,000 billion...

      While revenues only 129 million and loss widened to $71.3 million aka loss $1.06 per share.

      (From earnings report)
      👍️0
      make it happen make it happen 3 years ago
      Was $1.76 5 years ago. Up over 66% in 2 days up about $500,000,000 today alone. While loss widened to $1.06 per share.
      👍️0
      bwolfy2002 bwolfy2002 3 years ago
      Haha, but no in reality I think their acquiring of PGNX threw off some of their metrics and they are progressing, as they said they would, back to their targets where they feel more comfortable.
      👍️0
      bwolfy2002 bwolfy2002 3 years ago
      Dare I say LL?
      👍️0
      Chuckles759 Chuckles759 3 years ago
      Any thoughts at why LNTH is back near 52W highs, no significant news (as far as I can tell), and even a couple of insider sells ?

      👍️0
      Monroe1 Monroe1 3 years ago
      Should it get back down to 20 or so, I will grab some more.
      👍️0
      Monroe1 Monroe1 4 years ago
      thanks.

      No PM at this time.

      Fauci and Friends are bad news.
      👍️0
      Chuckles759 Chuckles759 4 years ago
      The royalties situation is quite confusing.

      The Progenics/Lantheus one is pretty clear cut. The AbbVie one is a little murky. The PDL one is like....WTF....

      I'm pretty sure all the agreements are on NET sales...not gross. I'll leave it up to the accountants and lawyers how that all gets divided up. It could all add up to 10-12%....but, hell...either having to pay 12% or receive 12% is a lot better than ZERO!!

      Approval & Sales for CytoDyn is what is going to get the gravy train rolling.
      👍️0
      bwolfy2002 bwolfy2002 4 years ago
      Do they ever mention the Royalties from Lero?
      👍️0
      Chuckles759 Chuckles759 4 years ago
      $LNTH is creeping toward my strike price....going to try taking advantage.


      Check out the news for their Sep 10th presentation. Wonder if they'll mention Progenics royalties from PRO 140.

      https://ih.advfn.com/stock-market/NASDAQ/lantheus-LNTH/stock-news/83193206/lantheus-holdings-to-present-at-the-wells-fargo-20


      https://investor.lantheus.com/events/event-details/wells-fargo-2020-virtual-healthcare-conference
      👍️0
      Chuckles759 Chuckles759 4 years ago
      Now. The Billion Dollar question is what would Lantheus Holdings do with a unbooked $25M for this year? What would it do with $120M+ for future years?

      I'm thinking two things:

      1) Stock buy backs to go back private - usually makes price go up.

      2) Use extra revenue to expand product line making company more valuable.

      Either way it gives me promise that my investment will grow somewhat independent of CYDY's success. LNTH isn't "tied" to CYDY, it's just that CYDY royalty payments give LNTH more promise for the future.
      👍️0
      SmileyRiley_595 SmileyRiley_595 4 years ago
      There are various levels of risk associated with differing investments... I have a substantial position in CYDY based on my belief in their science and potential... Finding arbitrages in undervalued securities like we believe may be the case with LNTH is worth consideration.
      👍️0
      7realone7 7realone7 4 years ago
      Thank you for your reply. I regularly read your (and those of some others) contributions on the CyDy thread.
      Right now I *only* own CyDy shares. Have sold everything else in January. By the way I am on the "other" board, because of obvious hopeful and fact based reasons. Somehow I cannot believe LNTH has more potential than CyDy.
      Take a look at the amount of outstanding shares and the forthcoming catalysts.
      I am far from your experience and knowledge level so don't take advice from me :D. Have a great day !

      👍️0
      SmileyRiley_595 SmileyRiley_595 4 years ago
      LNTH success doesn’t count on CYDY alone... What you should consider and ask yourself... Has the market has taken into consideration the impact PRO140/Leronlimab royalties impact the LNTH? At this point, I’m not so sure it has... More DD is needed and that’s what a few of us are currently doing.
      👍️0
      7realone7 7realone7 4 years ago
      I have a question. If I get it right LNTH's success highly depends on CyDy's success. May I ask why someone wouldn't just buy more CyDy shares instead of LNTH?
      The risk I see is some kind of dilution caused by LNTH. But I have no experience at all in this topic.
      👍️0
      Chuckles759 Chuckles759 4 years ago
      Looks like there was some insider sales and option awards recently. The ones posted here are difficult to read.

      Try these:

      https://www.secform4.com/insider-trading/1521036.htm
      👍️0
      SmileyRiley_595 SmileyRiley_595 4 years ago
      I’m also going to complete more DD... I certainly don’t know enough to jump in with both feet but, I would be tempted if the stock got down into the low $10 range to take a position on what I currently see...
      👍️0
      SmileyRiley_595 SmileyRiley_595 4 years ago
      That 9.4 million share trade on 6/19 just a few days before the merger w/ Progenics stands out like a “look at me”!!! I think there’s potential here... Unlike hopesters incorrect analysis of CYDY, LNTH is currently in a long term downward trend trading below it’s 20, 50, and 200 day moving averages... I haven’t bought in yet but, I’m strongly considering it right now!
      👍️0
      Chuckles759 Chuckles759 4 years ago
      Still doing my homework but I'm thinking they'll get the 5% for 10 years that Progenics agreed upon first PRO 140 commercial sale.

      I think there's another 5% that goes to Abbvie also.

      Since the turnover of PRO 140 to CytoDyn was so long ago, those costs have been absorbed/written off the books and whatever royalty revenue LNTH/ABBV gets is going to fatten up their quarterly income statements.

      I'll do some digging and slide it to you via email.
      👍️0
      Chuckles759 Chuckles759 4 years ago
      Riley,

      I'd love to mod the board but I've got my hands full for the remainder of the year. Also, I'm probably on the "bad boy" list also...not too far from your name.

      I haven't bought into LNTH yet. I've got an order in that hasn't triggered yet if it dips for some reason. Going to use a little TA and a gut feeling on entry price.
      👍️0
      SmileyRiley_595 SmileyRiley_595 4 years ago
      I was apparently turned down to be a moderator on this board... Probably Mod-Squad the admin associated with justdalies and his $5.95ers was the one the approval request went to (lol)



      But, in all seriousness... This is looking like a play with solid potential! Have most of you already taken a position or, are you looking to see if it breaks support at these levels? I was talking to hopester and he assured me the trend was down on this stock!!!
      👍️0
      SmileyRiley_595 SmileyRiley_595 4 years ago
      Also, what about their management team?
      👍️0
      SmileyRiley_595 SmileyRiley_595 4 years ago
      You have any intel that you could share on LNTH financial connection up CYDY
      👍️0
      SmileyRiley_595 SmileyRiley_595 4 years ago
      I’m thinking I might like that...
      👍️0
      Chuckles759 Chuckles759 4 years ago
      You realize that there is no moderator for this board yet. Bob requested but hasn't been granted yet.

      LNTH might be bulking up with royalty payments soon.

      You want to be "in charge"? Request to be a mod here and get to do Justa's job.
      👍️0
      SmileyRiley_595 SmileyRiley_595 4 years ago
      The $5.95 was for the white elephant gift exchange, other gifts have a $59.50 limit, and by no means should any gifts exceed $595.00...(-;
      👍️0
      Chuckles759 Chuckles759 4 years ago
      Smiley,

      I've been attempting to tweak my CYDY/LNTH revenue projection spreadsheets to figure out what budget I can set for my Christmas List this year.

      Trying to understand the Christmas party rules for gift giving. Was it a max of $5.95 per gift this year? How much are the mugs going to sell for?

      Also...my signature line below has some ideas....
      👍️0
      SmileyRiley_595 SmileyRiley_595 4 years ago
      Ok... I guess I really need to start paying attention and completing some DD on LNTH...
      👍️0
      Black-Ops Black-Ops 4 years ago
      First time I have been on the LNTH Board.. Darn right I think LNTH will be huge.

      Lets use Chuckles numbers. 4X in share price moves per One Billion in revs CYDY delivers.

      Lets cheat. Use a formula of 40$ per billion from CYDY.

      CYDY delivers the first 1 Billion 10 more billion will follow. Meaning? 450$ per share. Profit margin on the first 50,000,000$ license agreement payment should be close to 99.9999%

      My Big Picture for CYDY is not just 10 billion.

      This means LNTH will be a monster.

      👍️0
      Chuckles759 Chuckles759 4 years ago
      Tempting....but I'm about to engage moving homes three states over with kids in new schools, pets, a job change... lions and tigers...oh, my....

      Maybe after the dust settles, CYDY allows me to retire early (doubtful at this pace)....I'll certainly take it under advisement.

      I pulled back my buys on LNTH this morning and repurposed the cash for CYDY and got more @ $4.25. Didn't think it would hit...but it did easily.

      Depending on the trajectory of both, might break some cash loose to buy into LNTH if it doesn't take off.

      I think Black-Ops is also thinking LNTH will also start taking off soon if CYDY gets rolling.
      👍️0

      Your Recent History

      NASDAQ
      LNTH
      Lantheus
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads